| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.00 | 0.01 | 0.04 | 0.07 | 0.08 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.02 | 0.04 | 0.05 |
| Current Ratio | 3.74 | 3.21 | 2.95 | 3.44 | 3.17 |
| Fixed Assets | 1.25 | 1.26 | 1.13 | 1.05 | 1.29 |
| Inventory | 5.36 | 4.84 | 4.19 | 4.09 | 4.66 |
| Debtors | 2.75 | 3.26 | 3.37 | 3.48 | 3.42 |
| Interest Cover Ratio | 477.80 | 129.68 | 62.79 | 40.34 | 299.25 |
| PBIDTM (%) | 45.94 | 45.82 | 44.45 | 41.71 | 55.39 |
| PBITM (%) | 41.41 | 40.55 | 38.12 | 34.69 | 50.93 |
| PBDTM (%) | 45.85 | 45.51 | 43.85 | 40.85 | 55.22 |
| CPM (%) | 35.61 | 35.24 | 34.24 | 32.07 | 42.61 |
| APATM (%) | 31.08 | 29.97 | 27.91 | 25.05 | 38.14 |
| ROCE (%) | 29.62 | 28.81 | 26.05 | 21.86 | 32.82 |
| RONW (%) | 22.35 | 21.63 | 19.85 | 16.95 | 26.59 |